The global dental biomaterials market is anticipated to reach market size of around US$ 12,000 Mn by 2027 and is anticipated to grow at a CAGR of around 7% in terms of revenue during the forecast period 2020 - 2027. Dental biomaterials are advanced devices for dentistry use. It is constructed devices that repair the lost or missing teeth. Other than substituting degraded or absent dental tissues, dental biomaterials even facilitate tooth regeneration and avoid healthy dental tooth. The Dental biomaterials Centre, by material science research and engagement, focuses on preserving and returning oral health to patients. Dental biomaterials are composed of natural tissues and synthetic biocompatible materials.

Market Insights

Dental and oral health costs and the increased use of novel sticking products, CAD/CAM (computer-aided-design and computer-aided-manufacturing) resin cement and other digitals are propelled by the growing growth in dentistry and the increasing geriatric population. The use of new products and the collection of data require dental CAD/CAM technology. It is a non-destructive way to preserve thoughts, restorations and data on a device and serves as a contact medium for assessment. The number of disabled people living globally those from 2.5 million in 1990 to 4.5 billion in 2018, with 64% rise in disability-adjusted life years (DALYs) caused by oral diseases based on a systemic research report on the global burden of illness, disabilities and risk factors. Another important driver for market growth is the growth of disposable income and dentists, particularly in developing countries. For example, Brazil has 174,000 dentists in 2019, comprising 11% of the total world population, according to Brazilian Institute of Geography and Statistics (IBGE). In most developed countries too, the introduction of beneficial policies and initiatives is on the rise. The government of Brazil adopted the National Oral Health Program in 2014. Oral health understanding has been dramatically increased since the Program was initiated and dental expenses have been significantly increased in the region. The US has risen dental spending as a result of recognition, a growth in affordability and the propensity to cosmetic dentistry.

The estimated timeframe would be constrained by the high cost of care, rigorous regulatory and clinical procedures and inadequate insurance coverage. According to the World Health Organization (WHO,) oral diseases are one of the most costly diseases to contend with both in developing and developed countries every year. According to the Organization for Economic Co-operation and Development (OECD), in 2018, 7% of total health spending in developed countries paid for treatment of oral disorders, including dental biomaterials. Significant areas of dental treatment in developed countries are invested off the pockets, such as China's present basic insurance cover just a small part of dental expenses and more than 85% of overall expenses are charged off the pockets.

In 2019, North America prevailed and reflected a market share of 35.5% and is predicted to continue to prevail throughout the projected period. This has been attributed to increased government spending on oral health, an expanding elderly population and increasing the usage of dental biomaterials for dental drugs and other implants. Also one of the reasons for business growth in this area is the growing number of dental clinics and hospitals. Due to the rising occurrence of tooth disease, Asia Pacific is estimated to retain a substantial market share throughout the provision era. The field is one of the heavily populated regions of the world, with India and China as emerging economic giants, the world's two populous nations. The Asia-Pacific survey in 2018 revealed that oral requirements had a tremendous burden. Around 3 to 6.5 out of 10 people in this area are afflicted by oral illness. The burden of oral disease is likely to rise in the future with rising longevity. Furthermore, increasing medical tourism is projected to fuel business growth in the region in the developing economies. In some areas, including the Middle East, African and Latin America, profitable growth is expected in the foreseeable future as the industry in these areas is growing rapidly.

With the involvement of local and foreign companies the dental biomaterials industry is moderately competitive. The foreign firms take a large market share, while small and medium-sized businesses contend intensively with emerging technology. In the future, the market share is projected to be divided among foreign players and small players because creative goods will be generated by new entries. Some of the industry players include Geistlich Pharma AG, Institut Straumann AG, Zimmer Biomet Holdings, Dentsply Sirona, Inc., Danaher Corporation, Medtronic Plc, 3M Company, Carpenter Technology Corporation, Royal DSM, Kuraray Co. Ltd., and others.

The global dental biomaterials market is segmented as below:

Market Segmentation

Dental Biomaterials Market By Type

Metallic Biomaterials

Titanium

Stainless Steel

Chromium Alloys

Other Metallic Biomaterials

Ceramic Biomaterials

Metal-Ceramic

Polymeric Biomaterials

Natural Biomaterials

Dental Biomaterials Market By Application

Implantology

Prosthodontics

Orthodontics

Dental Biomaterials Market By End User

Dental Product Manufacturers

Dental Laboratories

Dental Hospital & Clinics

Dental Academic & Research

Dental Biomaterials Market By Geography

North America

• U.S
• Canada

Europe

• UK
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC
• South Africa
• Rest of Middle East & Africa

TABLE OF CONTENT